Title: URL Source: https://is.gd/T3EcFG Markdown Content: Investment Objective The WisdomTree Enhanced Commodity UCITS ETF - CHF Hedged Acc (the “Fund”) seeks to track the performance, before fees and expenses of the Optimized Roll Commodity Monthly CHF - Hedged Total Return Index (the "Index") . The Fund also aims to outperform the Bloomberg Commodity Index TR over the long term . The Fund invests in US Treasury Bills and uses total return swaps to deliver the Index performance . The swaps are collateralised on a daily basis and reset monthly . # Index Description The Index is a Swiss Franc denominated index whose main objective is to provide a broad and diversified UCITS compliant commodity exposure, covering four broad commodity sectors : Energy, Agriculture, Industrial Metals and Precious Metals . The Index uses futures to track the performance of the individual constituents of the Bloomberg Commodity Index TR . The Index employs a rule based approach for each of its components when it 'rolls' from one futures contract to another for each commodity in the Index . Rather than selecting the new future based on a predefined schedule (e .g. monthly) the Index rolls to the future which generates the maximum implied roll yield . The Index aims to maximise the potential roll benefits in backwardated markets and minimise the loss from rolling down the curve in contango markets . The currency hedging methodology consists of entering into a one -month forward currency contract (a contract between two parties to buy or sell a specific currency in the future at an agreed upon exchange rate) in order to hedge the underlying foreign currency exposure arising as a result of the difference between the Swiss Franc and the US Dollar . # Average Return Each Year (CHF) Name QTR YTD 1-Year 3-Year Inception Date COMS NAV 5.85% 5.85% 4.04% -5.72% 5.09% Source : WisdomTree UK, Bloomberg, as of 31 /03 /2025 . Performance for the fund and the index is shown in the listing currency . The fund performance is given net of fees . Investors should be aware that fees have a detrimental impact on the performance of an ETF . Please note this data refers to past performance and is not an indicator for future results and should not be the sole factor of consideration when selecting a product . Performance of less than one year is cumulative . COMS WisdomTree Enhanced Commodity UCITS ETF - CHF Hedged Acc 1 ## WisdomTree.eu ## +44 (0) 207 448 4330 ## Document Date: 31/03/2025 # COMS WisdomTree Enhanced Commodity UCITS ETF - CHF # Hedged Acc Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of the Prospectus titled ‘Risk Factors’ for further details of risks associated with an investment in this product . # Product Information Asset Class Commodities Benchmark Optimized Roll Commodity Monthly CHF -Hedged Total Return Index Replication Method US TBills With Swap Overlay Total Expense Ratio 0.35% Annual Swap Rate 0.35% Base Currency CHF Use of Income Accumulating Distribution Frequency N/A Inception Date 11/12/2019 Financial Year End 31 December UCITS Compliant Yes ISA Eligible Yes SIPP Eligible Yes EU Savings Directive Out of Scope Registration AT, CH, DE, DK, ES, FI, GB, IE, IT, LU, NL, SE Manager WisdomTree Management Ltd. Investment Manager Assenagon Asset Management S.A Administrator State Street Fund Services (Ireland) Limited Custodian State Street Custodial Services (Ireland) Limited # Index Information Index Optimized Roll Commodity Monthly CHF -Hedged Total Return Index Index Provider BNP Paribas Index Currency USD Index Bloomberg Code EBCIWTCT # ESG Characteristics SFDR Disclosure SFDR Article 6 MSCI ESG Fund Rating N/A COMS WisdomTree Enhanced Commodity UCITS ETF - CHF Hedged Acc 2 Index Sector Exposure 35.96% 29.28% 20.10% 14.66% Agricultural Energy Precious Metals Industrial Metals # empty Top 10 Holdings (% Weight) 15.54% 8.77% 7.31% 6.35% 5.95% 5.43% 5.30% 4.57% 3.91% 3.67% Gold Natural Gas Brent Crude WTI Crude Oil Soybeans Copper Corn Silver Aluminium Live Cattle Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of the Prospectus titled ‘Risk Factors’ for further details of risks associated with an investment in this product . NB : Sources for all tables/charts on these pages : WisdomTree UK, Bloomberg . All data as of 31 /03 /2025 # Listing Information Exchange Trading Currency Exchange Ticker Bloomberg Code RIC SEDOL ISIN WKN Listing Date SIX CHF COMS COMS SW COMS.S BG88WL2 IE00BG88WL21 A2P0YZ 16/12/2019 COMS WisdomTree Enhanced Commodity UCITS ETF - CHF Hedged Acc 3 # Potential Benefits Diversified index which provides broad commodity exposure . Designed to maximise potential roll returns by selecting the futures contract with the highest implied roll yield for each commodity . Proceeds are invested in T-Bills, and collateral consists of G7 bonds . Currency volatility is minimised through the use of currency forward contracts . The ETF is physically backed and UCITS compliant . # Potential Risks The returns payable on the Fund are dependent on payments received by the Fund from the swap counterparty under the terms of the relevant swap and therefore are subject to the credit risk of the swap counterparty . The performance of commodity indices may differ significantly from spot commodity prices . An investment in commodities may experience high volatility and should be considered as a longer term investment . Investment risk may be concentrated in specific sectors, countries, companies or currencies . The return of the forward currency contracts, which are rolled on a monthly basis, are designed to minimise currency fluctuations but may not perfectly offset the actual fluctuations . This list does not cover all risks -further risks are disclosed in the KID/KIID and Prospectus . Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of the Prospectus titled ‘Risk Factors’ for further details of risks associated with an investment in this product .COMS WisdomTree Enhanced Commodity UCITS ETF - CHF > Hedged Acc 4 # Glossary Dividend Weighted Index : an index that determines the weight of its constituents using the dividends paid by the security rather than another variable (the most common is Market Cap weighted indices) . Fully Replicated : assets are invested in securities that match the constituents of the relevant index, in the same proportion . Fundamentally Weighted Index : an index that weights securities on the basis of factors such as dividends or earnings . Large Cap, Mid Cap and Small Cap : refers to market capitalisation and is calculated by multiplying the price of a stock by the number of shares outstanding . Listing currency : the trading currency on the exchange . Physical (Optimised) : assets are predominantly invested in securities that are constituents of the index, but may also hold securities whose characteristics closely resemble the characteristics of the index . Physically Backed : securities held by the fund are the actual securities not a derivative . Rebalance : An index is created by applying a certain set of selection and weighting rules of countries, sectors and stocks at a certain frequency . A Rebalance is when WisdomTree re -applies its rules based selection and weighting process . Rebalance Frequency : The frequency by which the constituents of the index are screened and their weights changed . Replication Method : the method by which the fund gets exposure to the benchmark index . Share class currency or the "NAV currency" : The currency that the fund's NAV is issued in . Total Expense Ratio (TER) : A measure of the total costs associated with managing and operating a fund . The TER consists primarily of management fees plus other expenses such as trustee, custody and operating expenses . It does not cover the swap fee . The TER is expressed as a percentage of the fund's total net asset value . > Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of > the Prospectus titled ‘Risk Factors’ for further details of risks associated with an investment in this product . # Disclaimer IMPORTANT INFORMATION Marketing communications issued in the European Economic Area (“EEA”) : This document has been issued and approved by WisdomTree Ireland Limited, which is authorised and regulated by the Central Bank of Ireland . Marketing communications issued in jurisdictions outside of the EEA : This document has been issued and approved by WisdomTree UK Limited, which is authorised and regulated by the United Kingdom Financial Conduct Authority . WisdomTree Ireland Limited and WisdomTree UK Limited are each referred to as “WisdomTree” (as applicable) . Our Conflicts of Interest Policy and Inventory are available on request . This marketing communication has been prepared for professional investors, but the WisdomTree products set out in this document may be available in some jurisdictions to any investors, subject to applicable laws and regulations . As the product may not be authorised or its offering may be restricted in your jurisdiction, it is the responsibility of every person or entity to satisfy themselves as to the full observance of the laws and regulations of the relevant jurisdiction . Prior to any application investors are advised to take all necessary legal, regulatory, tax and investment advice on the suitability and consequences of an investment in the products . Past performance is not a reliable indicator of future performance . Any historical performance included in this document may be based on back testing . Back testing is the process of evaluating an investment strategy by applying it to historical data to simulate what the performance of such strategy would have been . Back tested performance is purely hypothetical and is provided in this document solely for informational purposes . Back tested data does not represent actual performance and should not be interpreted as an indication of actual or future performance . The value of any investment may be affected by exchange rate movements . Any decision to invest should be based on the information contained in the appropriate prospectus and after seeking independent investment, tax and legal advice . These products may not be available in your market or suitable for you . The content of this document does not constitute investment advice nor an offer for sale nor a solicitation of an offer to buy any product or make any investment . An investment in exchange -traded products (“ETPs”) is dependent on the performance of the underlying index, less costs, but it is not expected to match that performance precisely . ETPs involve numerous risks including among others, general market risks relating to the relevant underlying index, credit risks on the provider of index swaps utilised in the ETP, exchange rate risks, interest rate risks, inflationary risks, liquidity risks and legal and regulatory risks . The information contained in this document is not, and under no circumstances is to be construed as, an advertisement or any other step in furtherance of a public offering of shares in the United States or any province or territory thereof, where none of the issuers or their products are authorised or registered for distribution and where no prospectus of any of the issuers has been filed with any securities commission or regulatory authority . No document or information in this document should be taken, transmitted or distributed (directly or indirectly) into the United States . None of the issuers, nor any securities issued by them, have been or will be registered under the United States Securities Act of 1933 or the Investment Company Act of 1940 or qualified under any applicable state securities statutes . This document may contain independent market commentary prepared by WisdomTree based on publicly available information . Although WisdomTree endeavours to ensure the accuracy of the content in this document, WisdomTree does not warrant or guarantee its accuracy or correctness . Any third party data providers used to source the information in this document make no warranties or representation of any kind relating to such data . Where WisdomTree has expressed its own opinions related to product or market activity, these views may change . Neither WisdomTree, nor any affiliate, nor any of their respective officers, directors, partners, or employees accepts any liability whatsoever for any direct or consequential loss arising from any use of this document or its contents . This document may contain forward looking statements including statements regarding our belief or current expectations with regards to the performance of certain assets classes and/or sectors . Forward looking statements are subject to certain risks, uncertainties and assumptions . There can be no assurance that such statements will be accurate and actual results could differ materially from those anticipated in such statements . WisdomTree strongly recommends that you do not place undue reliance on these forward -looking statements . The products discussed in this document are issued by WisdomTree Issuer ICAV (“WT Issuer”) . WT Issuer is an umbrella investment company with variable capital having segregated liability between its funds organised under the laws of Ireland as an Irish Collective Asset -management Vehicle and authorised by the Central Bank of Ireland (“CBI”) . WT Issuer is organised as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the laws of Ireland and shall issue a separate class of shares ("Shares”) representing each fund . The Fund is described in a Key Information Document (KID) or Key Investor Information Document (KIID) for UK investors, and the prospectus of WT Issuer (“WT Prospectus”) . A copy of the WT Prospectus and the KID / KIID is available, for EEA/UK only, in English at www .wisdomtree .eu . Where required under national rules, the KID will also be available in the local language of the relevant EEA Member State . Investors should read the WT Prospectus before investing and should refer to the section of the WT Prospectus entitled ‘Risk Factors’ for further details of risks associated with an investment in the Shares . The summary of investor rights (https ://www .wisdomtree .eu/ -/media/eu -media -files/other -documents/regulatory/summary -of -investor -rights ---wisdomtree - issuer -icav .pdf) associated with an investment in the fund is available in English on WisdomTree Europe’s website . WisdomTree Management Limited may decide to terminate the arrangements made for the marketing of its collective investment undertakings . In such circumstances, shareholders in the affected EEA Member State will be notified of this decision and will be provided with the opportunity to redeem their shareholding in the fund free of any charges or deductions for at least 30 working days from the date of such notification .The methodology of and rules governing the index (the "Index Methodology" and the "Index") are proprietary and shall not be reproduced or disseminated without the prior written consent of the “Index Sponsor” (as defined in the “Index Rules” available on http ://www . Wisdomtree . Eu/home) . None of the Index Sponsor, the index calculation agent (where such party is not also the Index Sponsor, the "Index Calculation Agent") nor, where applicable, the index Investment Advisor (the "Index Investment Advisor") guarantee that there will be no errors or omissions in computing or disseminating the Index . The Index Methodology is based on certain assumptions, certain pricing models and calculation methods adopted by the Index Sponsor, the Index Calculation Agent and, where applicable, the Index Investment Advisor, and may have certain inherent limitations . Information prepared on the basis of different models, calculation methods or assumptions may yield different results . You have no authority to use or reproduce the Index Methodology in any way, and neither the Index Sponsor nor any of its affiliates shall be liable for any loss whatsoever, whether arising directly or indirectly from the use of the Index or Index Methodology or otherwise in connection therewith . The Index Sponsor reserves the right to amend or adjust the Index Methodology from time to time in accordance with the rules governing the Index and accepts no liability for any such amendment or adjustment . Neither the Index Sponsor nor the Index Calculation Agent are under any obligation to continue the calculation, publication or dissemination of the Index and accept no liability for any suspension or interruption in the calculation thereof which is made in accordance with the rules governing the Index . None of the Index Sponsor, the Index Calculation Agent nor, where applicable, the Index Investment Advisor accept any liability in connection with the publication or use of the level of the Index at any given time . The Index Methodology embeds certain costs in the strategy which cover amongst other things, friction, replication and repo costs in running the Index . The levels of such costs (if any) may vary over time in accordance with market conditions as determined by the Index Sponsor acting in a commercially reasonable manner . The Index Sponsor and its affiliates may enter into derivative transactions or issue financial instruments (together, the "Products") linked to the Index . The Products are not in any way sponsored, endorsed, sold or promoted by the sponsor of any index component (or part thereof) which may comprise the Index (each a "Reference Index") that is not affiliated with BNP Paribas (each such sponsor, a "Reference Index Sponsor") . The Reference Index Sponsors make no representation whatsoever, whether express or implied, either as to the results to be obtained from the use of the relevant Reference Index and/or the levels at which the relevant Reference Index stands at any particular time on any particular date or otherwise . No Reference Index Sponsor shall be liable (whether in negligence or otherwise) to any person for any error in the relevant Reference Index and the relevant Reference Index Sponsor is under no obligation to advise any person of any error therein . None of the Reference Index Sponsors makes any representation whatsoever, whether express or implied, as to the advisability of purchasing or assuming any risk in connection with the Products . The Index Sponsor and its affiliates have no rights against or recourse to any Reference Index Sponsor should any Reference Index not be published or for any errors in the calculation thereof or on any other basis whatsoever in relation to any Reference Index, its production, or the level or constituents thereof . The Index Sponsor and its affiliates shall have no liability to any party for any act or failure to act by any Reference Index Sponsor in connection with the calculation, adjustment or maintenance of the relevant Reference Index and have no affiliation with or control over any Reference Index or the relevant Reference Index Sponsor or the computation, composition or dissemination of any Reference Index . Although the Index Calculation Agent will obtain information concerning each Reference Index from publicly available sources that it believes reliable, it will not independently verify this information . Accordingly, no representation, warranty or undertaking (express or implied) is made and no responsibility is accepted by the Index Sponsor or any of its affiliates nor the Index Calculation Agent as to the accuracy, completeness and timeliness of information concerning any Reference Index . The Index Sponsor and/or its affiliates may act in a number of different capacities in relation to the Index and/or products linked to the Index, which may include, but not be limited to, acting as market -maker, hedging counterparty, issuer of components of the Index, Index Sponsor and/or Index Calculation Agent . Such activities could result in potential conflicts of interest that could influence the price or value of a Product .Additional Information Notice to Investors in Switzerland – Qualified Investors : This document constitutes an advertisement of the financial product(s) mentioned herein . The prospectus and the key investor information documents (KIID) are available from WisdomTree’s website : https ://www .wisdomtree .eu/en -ch/resource - library/prospectus -and -regulatory -reports Some of the sub -funds referred to in this document may not have not been registered with the Swiss Financial Market Supervisory Authority ("FINMA”) . In Switzerland, such sub -funds that have not been registered with FINMA shall be distributed exclusively to qualified investors, as defined in the Swiss Federal Act on Collective Investment Schemes or its implementing ordinance (each, as amended from time to time) . The representative and paying agent of the sub -funds in Switzerland is Société Générale Paris, Zurich Branch, Talacker 50 , PO Box 5070 , 8021 Zurich, Switzerland . The prospectus, the key investor information documents (KIID), the articles of association and the annual and semi -annual reports of the sub -funds are available free of charge from the representative and paying agent . As regards distribution in Switzerland, the place of jurisdiction and performance is at the registered seat of the representative and paying agent . For Investors in France : The information in this document is intended exclusively for professional investors (as defined under the MiFID) investing for their own account and this material may not in any way be distributed to the public . The distribution of the Prospectus and the offering, sale and delivery of Shares in other jurisdictions may be restricted by law . WT Issuer is a UCITS governed by Irish legislation, and approved by the Central Bank of Ireland as UCITS compliant with European regulations although may not have to comply with the same rules as those applicable to a similar product approved in France . The Fund has been registered for marketing in France by the Financial Markets Authority (Autorité des Marchés Financiers) and may be distributed to investors in France . Copies of all documents (i .e. the Prospectus, the Key Investor Information Document, any supplements or addenda thereto, the latest annual reports and the memorandum of incorporation and articles of association) are available in France, free of charge at the French centralizing agent, Societe Generale at 29 , Boulevard Haussmann, 75009 ,Paris, France . Any subscription for Shares of the Fund will be made on the basis of the terms of the prospectus and any supplements or addenda thereto .